Phase 3 Lung Cancer Clinical Trials
12 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–12 of 12 trials
Recruiting
Phase 2Phase 3
Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer
Lung Cancer
Canadian Cancer Trials Group230 enrolled10 locationsNCT04093167
Recruiting
Phase 3
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
Prostate CancerLung CancerColo-rectal Cancer+1 more
Roswell Park Cancer Institute800 enrolled1 locationNCT06563388
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Lung CancerEGFRNSCLC, Stage IB-IIIA+5 more
Taiho Oncology, Inc.360 enrolled214 locationsNCT07128199
Recruiting
Phase 3
The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III
Esophageal CancerGastric CancerLung Cancer
Ottawa Hospital Research Institute20 enrolled2 locationsNCT04871412
Recruiting
Phase 2Phase 3
Trop2-targeted immunoPET Imaging of Solid Tumors
Liver CancerOvarian CancerCervical Cancer+11 more
RenJi Hospital400 enrolled1 locationNCT06851663
Recruiting
Phase 3
tislelizUMaB in canceR Patients With molEcuLar residuaL Disease
Soft Tissue SarcomaLung CancerCancer+2 more
Gustave Roussy, Cancer Campus, Grand Paris717 enrolled1 locationNCT06332274
Recruiting
Phase 3
Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Without Chemoimmunotherapy
Lung Cancer
Zhou Chengzhi180 enrolled1 locationNCT06607796
Recruiting
Phase 3
Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors
Lung Cancer
Hunan Province Tumor Hospital12,000 enrolled1 locationNCT05055908
Recruiting
Phase 2Phase 3
Interventional Software for Multi-immunotherapy of Solid Tumors
Liver CancerLung CancerSolid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University60 enrolled1 locationNCT06478108
Recruiting
Phase 2Phase 3
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Breast CancerOvarian CancerCervical Cancer+7 more
Second Affiliated Hospital of Guangzhou Medical University200 enrolled1 locationNCT03755739
Recruiting
Phase 3
PAlliative RAdioTherapy to Lung Cancer A Randomized Multicentre Phase III Study
Lung Cancer
University of Aarhus1,184 enrolled1 locationNCT03632603
Recruiting
Phase 3
MRD Guiding Treatment After Almonertinib Induction Therapy for EGFRm+ Stage III NSCLC in the MDT Diagnostic Model.
Lung Cancer
Guangdong Association of Clinical Trials192 enrolled1 locationNCT04841811